New medicines of added value in middle-income countries

被引:0
|
作者
Born, Adam
机构
关键词
urothelial carcinoma; nonmuscle invasive bladder tumors; cystodiathermy; transurethral resection of bladder tumors; fulguration;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Evaluation of: Park DS, Hwang JH, Gong IH et al. An analysis of the efficacy, safety, and cost-effectiveness of fulguration under local anesthesia for small-sized recurrent masses: a comparative analysis of transurethral resection of bladder tumors in a matched cohort. J. Endourol. 27(10), 1240-1244 (2013). At initial diagnosis, most bladder tumors are nonmuscle invasive. Some will recur after initial resection and will require transurethral resections of the bladder tumor. Fulguration under local anesthesia represents an alternative. This option is assessed in the article of Park et al. with respect to efficacy, safety and cost-effectiveness in patients with small-sized recurrent bladder tumors. The authors suggest that fulguration is safe and efficacious without compromising oncological outcomes in selected patients relative to formal transurethral resections of bladder tumor.
引用
收藏
页码:121 / 121
页数:1
相关论文
共 50 条
  • [1] Selection of oncology medicines in low- and middle-income countries
    Bazargani, Y. T.
    de Boer, A.
    Schellens, J. H. M.
    Leufkens, H. G. M.
    Mantel-Teeuwisse, A. K.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (01) : 270 - 276
  • [2] Essential medicines for COPD and asthma in low and middle-income countries
    Bazargani, Yaser T.
    de Boer, Anthonious
    Leufkens, Hubert G. M.
    Mantel-Teeuwisse, Aukje K.
    [J]. THORAX, 2014, 69 (12) : 1149 - 1151
  • [3] Quality assurance and cancer medicines in low-income and middle-income countries
    Tuck, Chloe
    Boaitey, Kwame Peprah
    Chan, Amy Hai Yan
    [J]. LANCET ONCOLOGY, 2021, 22 (03): : 301 - 303
  • [4] The European Medicines Agency facilitates access to medicines in low- and middle-income countries
    Cavaller Bellaubi, Maria
    Harvey Allchurch, Martin
    Lagalice, Clement
    Saint-Raymond, Agnes
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (03) : 321 - 325
  • [5] More value from health IT in low and middle-income countries
    Mousavi, Seyyed Meysam
    Takian, Amirhossein
    [J]. HEALTH POLICY AND TECHNOLOGY, 2020, 9 (03) : 283 - 284
  • [6] Access to medicines through health systems in low- and middle-income countries
    Ozawa, Sachiko
    Shenker, Raja
    Leopold, Christine
    Orubu, Samuel
    [J]. HEALTH POLICY AND PLANNING, 2019, 34 : 1 - 3
  • [7] Access to cardiovascular medicines in low- and middle-income countries: a mini review
    Harrison, Mark Amankwa
    Marfo, Afia Frimpomaa Asare
    Annan, Augustine
    Ankrah, Daniel Nii Amoo
    [J]. GLOBAL HEALTH RESEARCH AND POLICY, 2023, 8 (01)
  • [8] Access to cardiovascular medicines in low- and middle-income countries: a mini review
    Mark Amankwa Harrison
    Afia Frimpomaa Asare Marfo
    Augustine Annan
    Daniel Nii Amoo Ankrah
    [J]. Global Health Research and Policy, 8
  • [9] New Developmentalism: development macroeconomics for middle-income countries
    Bresser-Pereira, Luiz Carlos
    [J]. CAMBRIDGE JOURNAL OF ECONOMICS, 2020, 44 (03) : 629 - 646
  • [10] Added Value of Electronic Immunization Registries in Low- and Middle-Income Countries: Observational Case Study in Tanzania
    Secor, Andrew M.
    Mtenga, Hassan
    Richard, John
    Bulula, Ngwegwe
    Ferriss, Ellen
    Rathod, Mansi
    Ryman, Tove K.
    Werner, Laurie
    Carnahan, Emily
    [J]. JMIR PUBLIC HEALTH AND SURVEILLANCE, 2022, 8 (01):